Bortezomib
Products from producer
In stock
Reconfirm the price with seller
- Customer pickup,
- Courier
- In detail
Products of other enterprises
Technical characteristics
- Country of manufactureIndia
Description
Oncology-APIs
Our product range includes a wide range of Oncology-APIs such as Bortezomib, Bleomycin Sulphate, Busulfan, Daunorubicin Hydrochloride, Irinotecan Hydrochloride Trihydrate, Cladribine and many more items. |
Item Code: BTZ-01
Bortezomib (CAS Number: 179324-69-7)Bortezomib is a therapeutic proteosome inhibitor used to treat people with multiple myeloma, a cancer of the bone marrow. Bortezomib is also used to treat people with mantle cell lymphoma, a fast-growing cancer that affects the immune system). It acts by killing the cancer cells. Anxiety, back pain, numbness, rash, itching are some of the side effects of this dhenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-; Boronic acid, [1-[[1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl) amino]propyl]amino]-3-methylbutyrug.
- Chemical formula: C19H25BN4O4
- Synonyms:Pyz-Phe-boroLeu;Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-pl]-, L-(S)-;[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid;PS 341
- Molecular weight:384.24
- Melting Point: 122-124°C
- Assay : 99 %
- Boiling Point: 684.30°C at 760 mm Hg
- Appearance: White or almost white powder
- Packaging: 10/100g / bag
Contact the seller
Bortezomib
We recommend to see